Andere talen Control Bionics Limited

Aandelen

Vertraagde tijd Australian S.E. Andere beurzen 02:10:27 27-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,052 ^AUD	+4,00%		-8,77%	+13,04%

20/06	Control Bionics' DROVE autonome rolstoelmodule krijgt goedkeuring in Australië	MT
09/05	Control Bionics benoemt CFO	MT

Control Bionics' DROVE Autonomous Wheelchair Module Secures Australia Approval	20/06
Control Bionics Raises AU$130,000 via Additional Commitments for Placement	17/05
Control Bionics to Raise AU$1 Million via Share Placement	15/05
Control Bionics Appoints Corporate Advisor	13/05
Control Bionics Appoints CFO	09/05
Control Bionics Signs Multiple Award Schedule Contract with US Government	08/05
Australian Shares Jump to More than Three-Week High as Central Bank Holds Rates	07/05
Control Bionics Signs MoU for Japan Launch of NeuroStrip; Shares Up 13%	07/05
Control Bionics Registers Wearable Device with UK Medical Regulator	08/03
Control Bionics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Control Bionics Secures US Grant Funding to Develop Autonomous Wheelchair Device	24/01
Control Bionics Raises AU$1 Million Via Shortfall Placement	19/01
Control Bionics Receives AU$480,500 R&D Tax Rebate	22/11
Control Bionics Launches NeuroStrip Wearable Device	12-10-23
Control Bionics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Control Bionics Limited Provides Revenue Guidance for the Year Ended 30 June 2023	13-06-23
Control Bionics Limited Announces Unaudited Sales Results for the Month Ended May 2023	13-06-23
Control Bionics Limited Announces Directorate Changes	04-05-23
Morgans rates CBL as Speculative Buy	24-02-23
Control Bionics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23

Geen resultaten voor deze zoekopdracht